We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients

Product News   Sep 30, 2020

 
REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Researchers Tackle the Surface Transmission of COVID-19 in New Partnership

Product News

A project to develop surface treatments that can provide long-lasting protection against the COVID-19 virus has been launched at the University of Birmingham.

READ MORE

Heidelberg Pharma Contracts ProBioGen for Cell Line Development and Manufacturing Services

Product News

Berlin, a premier service and technology provider for complex therapeutic antibodies and glycoproteins, & Heidelberg Pharma AG, Ladenburg, Germany, today announced that Heidelberg Pharma has signed a Master Service Agreement for the antibodies used in two of their pipeline Antibody Targeted Amanitin Conjugate (ATAC) molecules.

READ MORE

Hydrophilic Vyon® Plastics Demonstrate High Performance for Drug Discovery Applications

Product News

Porvair Sciences reports on testing that demonstrates how its hydrophilic Vyon® porous plastics exhibit outstanding performance in drug discovery applications due to the high hydrophilic void volume conversion of the materials’ pore structure after a special treatment process.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE